Compare NICE & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NICE | MIR |
|---|---|---|
| Founded | 1986 | 2005 |
| Country | Israel | United States |
| Employees | 9626 | 3281 |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.5B |
| IPO Year | N/A | N/A |
| Metric | NICE | MIR |
|---|---|---|
| Price | $87.87 | $16.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $153.46 | $27.25 |
| AVG Volume (30 Days) | 710.4K | ★ 3.7M |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.14 | $23.95 |
| Revenue Next Year | $9.62 | $7.32 |
| P/E Ratio | ★ $11.21 | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $84.38 | $15.58 |
| 52 Week High | $175.00 | $30.28 |
| Indicator | NICE | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 38.90 | 35.91 |
| Support Level | $86.40 | N/A |
| Resistance Level | $116.83 | $18.68 |
| Average True Range (ATR) | 3.94 | 0.88 |
| MACD | -0.15 | -0.15 |
| Stochastic Oscillator | 19.06 | 17.15 |
Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.